Harleman Johannes H
Novartis Pharma AG, Global Head Pathology, SP&A, Pathology, MUT-2881, CH-4132 Muttenz, Switzerland.
Exp Toxicol Pathol. 2006 Jul;57(5-6):359-61. doi: 10.1016/j.etp.2006.03.006. Epub 2006 May 26.
Recently several guidelines were published on immunotoxicity. Validation studies have shown that detailed extended examination of the immune system is able to flag immunotoxic compounds. Parameters of the examination are presented. In the final examination it is important that the whole immune system is evaluated as one functional system--multiple sites but one system.
